IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Mar 17, 2022 · 10-K · 76 days after period end · 0000950170-22-004101
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|
| Net Income | -$5.85M | -$2.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 17, 2022 · 76 d after period end
